{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:06:25Z","timestamp":1744650385947},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>SUMMARY We describe the case of an eight-year-old boy with X-linked agammaglobulinemia who developed mild varicella despite regular intravenous immunoglobulin (IVIG) therapy. He maintained protective antibody levels against varicella and the previous batches of IVIG that he received had adequate varicella-specific IgG levels. The case illustrates that IVIG may not prevent VZV infection.<\/jats:p>","DOI":"10.1590\/s0036-46652015000500017","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T16:55:50Z","timestamp":1448038550000},"page":"455-457","source":"Crossref","is-referenced-by-count":5,"title":["PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT"],"prefix":"10.1590","volume":"57","author":[{"given":"Fernanda Aim\u00e9e","family":"NOBRE","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Garrido da Silva","family":"GONZALEZ","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel de","family":"MORAES-PINTO","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Tavares","family":"COSTA-CARVALHO","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2217\/imt.14.67","article-title":"An update on the use of immunoglobulin for the treatment of immunodeficiency disorders","volume":"6","author":"Albin S","year":"2014","journal-title":"Immunotherapy"},{"key":"ref2","series-title":"Red Book: 2012 report of the Committee on Infectious Diseases","first-page":"774","volume-title":"Varicella-zoster infections","author":"Pickering LK","year":"2012"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/506363","article-title":"Measles-virus-neutralizing antibodies in intravenous immunoglobulins","volume":"194","author":"Audet S","year":"2006","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","article-title":"Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency","volume":"28","author":"Berger M","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2006.01.017","article-title":"European seroepidemiology network 2: standardization of assays for seroepidemiology of varicella zoster virus","volume":"36","author":"De Ory F","year":"2006","journal-title":"J Clin Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.intimp.2005.11.003","article-title":"Differences between IGIV products:impact on clinical outcome","volume":"6","author":"Gelfand EW","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon AA","year":"2010","journal-title":"J Clin Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CMR.13.4.602-614.2000","article-title":"Passive immunity in prevention and treatment of infectious diseases","volume":"13","author":"Keller MA","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Maarschalk-Ellerbroek LJ","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"ref10","first-page":"634","article-title":"The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin","volume":"112","author":"Mankarious S","year":"1988","journal-title":"J Lab Clin Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2009-0047","article-title":"Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations","volume":"124","author":"Maranich AM","year":"2009","journal-title":"Pediatrics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2172-15-26","article-title":"Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study","volume":"15","author":"Nobre FA","year":"2014","journal-title":"BMC Immunol"},{"issue":"2 Suppl 2","key":"ref13","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo LD","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0036-46652004000300008","article-title":"A simple and cheaper in house varicella zoster virus antibody indirect ELISA","volume":"46","author":"Ono E","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero ME","year":"2009","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani A","year":"2002","journal-title":"Clin Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijid.2003.09.006","article-title":"A review of the varicella vaccine in immunocompromised individuals","volume":"8","author":"Sartori AMC","year":"2004","journal-title":"Int J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10875-010-9420-7","article-title":"Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen","volume":"30","author":"Viana PO","year":"2010","journal-title":"J Clin Immunol"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v57n5\/0036-4665-rimtsp-57-05-00455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T04:17:28Z","timestamp":1495513048000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652015000500455&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0036-46652015000500455"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652015000500017","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}